Silverlake Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,638
Closed -$234K 291
2024
Q2
$234K Buy
+1,638
New +$234K 0.1% 233